Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Convertible Debt: 2022-2025

Historic Convertible Debt for Mainz Biomed N.V (MYNZ) over the last 1 years, with Jun 2025 value amounting to $482,149.

  • Mainz Biomed N.V's Convertible Debt fell 91.75% to $482,149 in Q2 2025 from the same period last year, while for Jun 2025 it was $482,149, marking a year-over-year decrease of 91.75%. This contributed to the annual value of $1.1 million for FY2024, which is 77.69% down from last year.
  • According to the latest figures from Q2 2025, Mainz Biomed N.V's Convertible Debt is $482,149, which was down 55.93% from $1.1 million recorded in Q4 2024.
  • Mainz Biomed N.V's Convertible Debt's 5-year high stood at $5.8 million during Q2 2024, with a 5-year trough of $2,023 in Q3 2023.
  • Over the past 3 years, Mainz Biomed N.V's median Convertible Debt value was $788,062 (recorded in 2024), while the average stood at $2.1 million.
  • In the last 5 years, Mainz Biomed N.V's Convertible Debt skyrocketed by 11,287.95% in 2023 and then slumped by 91.75% in 2025.
  • Mainz Biomed N.V's Convertible Debt (Quarterly) stood at $43,057 in 2022, then surged by 11,287.95% to $4.9 million in 2023, then tumbled by 77.69% to $1.1 million in 2024, then slumped by 91.75% to $482,149 in 2025.
  • Its Convertible Debt stands at $482,149 for Q2 2025, versus $1.1 million for Q4 2024 and $5.8 million for Q2 2024.